1Baba T,Michikawa Y,Kashiwabara S,et al.Proacrosin activation in the presence of a 32-kDa protein from boar spermatozoa[J].Biochem Biophys Res Commun,1989,160(3):1026-1032.
2Baba T,Niida Y,Michikawa Y,et al.An acrosomal protein,sp32,in mammalian sperm is a binding protein specific for two proacosins and an acrosin intermediate[J].J Biol Chem.1994,269(13):10133-10140.
3Ono T,Kurashige T,Harada N,et al.Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen[J].Proc Natl Acad Sci U S A,2001,98(6):3282-3287.CHINESE JOURNAL OF ANATOMY Vol.30 No.4 2007
4Tardif S,Dubé C,Chevalier S,et al.Capacitation is associated with tyrosine phosphorylation and tyrosine kinase-like activity of pig sperm proteins[J].Biol Reprod,2001,63(3):784-792.
5Old L J.Cancer vaccine collaborative 2002:opening address[J].Cancer Immun,2003,3(Suppl 1):1.
2Scanlan MJ,Gure AO,Jungbluth AA,et al. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev,2002,188:22-32.
3Scanlan MJ, Simpson A J, Old LJ. The cancer/testis genes: review,standardization, and commentary. Cancer Immun ,2004,4:1.
4Lee SY, Obata Y,Yoshida M,et al. Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA ,2003,100 (5) :2651-2656.
5dos Santos NR,Torensma R,de Vries TJ,et al. Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. Cancer Res,2000,60(6) :1654-1662.
6Scanlan M J, Gordon CM, Williamson B,et al. Identification of cancer/ testis genes by database mining and mRNA expression analysis. Int J Cancer,2002,98 ( 4 ) :485-492.
7Luo G,Huang S,Xie X,et al. Expression of cancer-testis genes in human hepatocellular carcinomas. Cancer Immun ,2002,2:11.
8De Smet C, Lurquin C, Lethe B,et al. DNA methylation is the primary silencing mechanism for a set of germ line-and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol, 1999,19(11) :7327-7335.
9De Backer O, Arden KC, Boretti M, et al. Characterization of the GAGE genes that are expressed in various human cancers and in normal testis. Cancer Res,1999,59(13) :3157-3165.
10Sigalotti L,Coral S,Altomonte M,et al. Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications. Br J Cancer,2002,86 (6) :979-982.
2Almeida LG,Sakabe NJ,Oliveira AR,et al.CTdatabase:a knowledge-base of high-throughput and curated data on carer-lestis antigens[J].Nucleic Acids Res,2009,37:D816-819.
3Ghafouri-Fard S,Modarressi MH.Cancer-testis antigens:potential targets for cancer immunotherapy[J].Arch Iran Med,2009,12 (4):395-404.
4Güre AO,Stockert E,Arden KC,et al.CT10:a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family,identifid by representational difference analysis[J].Int J Cancer,2000,85(5):726-732.
5Tammela J,Ucnaka A,Ono T,et al.OY-TES-1 expression and serum immunoreactivity in epithelial ovarian canccr[J].Int J Oncol,2006,29(4):903-910.
7Cronwright G,Le Blane K,Gotherstron C,et al.Cancer/testis antigen expression in human mesenchymal stem cells:down regulation of SSX impairs cell migration and matrix metalloproteinase 2 expressin[J].Cancer Res,2005,65(6):2207-2215.
8Shim H,Shim E,Lee H,et al.CAGH,a novel cancer/testis antigen gene,promotes cell motility by activating ERK and p38 MAPK and down regulating ROS[J].Mol Cells,2006,21 (3):367-375.
9Ono T, Kurashige T, Harada N, et al. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen [J]. Proc Natl Acad Sci USA, 2001,98(6) :3282-3287.
10Imura M, Yamashita S, Cai LY, et al. Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines[ J]. Cancer Lett, 2006,241 (2) :213-220.
